home / stock / vapo / vapo news


VAPO News and Press, Vapotherm Inc. From 11/01/23

Stock Information

Company Name: Vapotherm Inc.
Stock Symbol: VAPO
Market: NYSE
Website: vapotherm.com

Menu

VAPO VAPO Quote VAPO Short VAPO News VAPO Articles VAPO Message Board
Get VAPO Alerts

News, Short Squeeze, Breakout and More Instantly...

VAPO - Expected earnings - Vapotherm Inc.

Vapotherm Inc. (VAPO) is expected to report $-2.2 for Q3 2023

VAPO - Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced the online public...

VAPO - GME, SSL and GRTS are among pre market gainers

2023-09-28 08:43:44 ET Chico's Fas ( CHS ) +63% soars 63% after landing buyout offer from Sycamore Partners. Gritstone  ( GRTS ) +27% . Peloton Interactive  ( PTON ) +14% joined forces - analysts don't expect huge upside. Vapotherm  (...

VAPO - Vapotherm HVNI technology outperforms standard oxygen therapy for treatment of acute asthma in children according to Pilot Study

2023-09-25 08:45:55 ET (24/7 MARKET NEWS) – Vapotherm, Inc. (NASDAQ:VAPO) reported, this morning, the presentation of an Investigator-initiated clinical trial, “High flow humidified oxygen as an early intervention in children with acute severe asthma – a feasibility ran...

VAPO - Vapotherm high velocity therapy outperforms in children with asthma

2023-09-25 07:49:02 ET More on Vapotherm Seeking Alpha’s Quant Rating on Vapotherm Historical earnings data for Vapotherm Financial information for Vapotherm Vapotherm, Inc. (VAPO) Q2 2023 Earnings Call Transcript Vapotherm reports mixed Q2 ear...

VAPO - Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children

Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced the presentation ...

VAPO - Vapotherm President/CEO buys 100,000 common shares

2023-09-11 11:13:24 ET More on Vapotherm Seeking Alpha’s Quant Rating on Vapotherm Historical earnings data for Vapotherm Financial information for Vapotherm Vapotherm reports mixed Q2 earnings; updates FY23 outlook For further details see: ...

VAPO - Vapotherm Inc. (NYSE: VAPO) Records 52-Week High Friday Morning

Shares of Vapotherm, Inc. (NYSE: VAPO) traded at a new 52-week high today and are currently trading at $3.01. So far today, approximately 16,999 shares have been exchanged, as compared to an average 30-day volume of 472.01k shares. Vapotherm, Inc., a medical technology company, focuses on the...

VAPO - Vapotherm, Inc. (VAPO) Q2 2023 Earnings Call Transcript

2023-08-08 23:04:02 ET Vapotherm, Inc. (VAPO) Q2 2023 Earnings Conference Call August 08, 2023, 04:30 PM ET Company Participants Mark Klausner - ICR Westwicke, IR Joe Army - President and CEO John Landry - SVP and CFO Conference Call Participants Jon ...

VAPO - Vapotherm reports mixed Q2 earnings; updates FY23 outlook

2023-08-08 17:56:56 ET Vapotherm press release ( NYSE: VAPO ): Q2 GAAP EPS of -$0.29 beats by $0.07 . Revenue of $16M (+23.1% Y/Y) misses by $1M . The Company’s unrestricted cash balance was $18.0 million at the end of the second quarter of 2023 Net ...

Previous 10 Next 10